New York, NY, United States of America

Angel Janevski

USPTO Granted Patents = 22 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 221(Granted Patents)


Location History:

  • New York City, NY (US) (2004 - 2006)
  • Briarcliff Manor, NY (US) (2015)
  • New York, NY (US) (2006 - 2022)

Company Filing History:


Years Active: 2004-2022

Loading Chart...
22 patents (USPTO):

Title: Innovator Spotlight: Angel Janevski

Introduction

Angel Janevski is a prominent inventor based in New York, NY. With an impressive portfolio of 22 patents, he has contributed significantly to the field of clinical decision support and molecular signatures. His inventions focus on enhancing the precision and interpretability of clinical data, proving crucial in the evolving landscape of healthcare technology.

Latest Patents

Angel Janevski's recent innovations include two notable patents. The first is centered around "Biomarkers based on sets of molecular signatures," which introduces a method for forming novel signatures of biological data. This method involves ranking features based on a trend value derived from multiple signatures identified through a pattern discovery approach. His invention offers applications in statistically analyzing clinical data, designing assays based on multiple molecular signatures, and interpreting those assays effectively.

The second patent, "System and method for real-time clinical questions presentation and management," outlines a clinical decision support method. It involves computing outputs from computer-implemented analytical modules tailored to a patient's needs. The method displays pertinent information regarding clinical questions, incorporating in silico genetic and genomic tests as well as other analytical data. This innovative system enables clinicians to manage patient care more effectively by streamlining the complexities associated with genomic data interpretation.

Career Highlights

Angel Janevski has had an illustrious career, working with leading companies in the field. His tenure at Koninklijke Philips Corporation N.V. and Fudan University allowed him to harness advanced technologies and contribute to meaningful developments in healthcare.

Collaborations

Throughout his career, Angel has collaborated with esteemed colleagues, including Nevenka Dimitrova and Vinay Varadan. These collaborations have further fueled his innovative endeavors, leading to impactful advancements in the medical and technological arenas.

Conclusion

Angel Janevski continues to be a driving force in innovation, particularly in the realm of clinical decision support and molecular biology. His ongoing contributions and impressive patent portfolio solidify his status as a key innovator in the industry. As technology and healthcare continue to converge, his work remains essential for advancing patient care and decision-making processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…